MicroRNA‑219a‑2‑3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway

Yang,Chuanjia; Zhang,Siyang; Chang,Xiaoying; Huang,Yonglian; Cui,Dongxu; Liu,Zhen

doi:10.3892/etm.2021.10091

June-2021 Volume 21 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

June-2021 Volume 21 Issue 6

Full Size Image

Article

MicroRNA‑219a‑2‑3p modulates the proliferation of thyroid cancer cells via the HPSE/cyclin D1 pathway

Authors:
- Chuanjia Yang
- Siyang Zhang
- Xiaoying Chang
- Yonglian Huang
- Dongxu Cui
- Zhen Liu
View Affiliations / Copyright

Affiliations: Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China, Science and Experiment Center, China Medical University, Shenyang, Liaoning 110122, P.R. China, Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
Article Number: 659
|
Published online on: April 20, 2021

https://doi.org/10.3892/etm.2021.10091
Expand metrics +

Abstract

Heparanase (HPSE) is an endo‑β‑D‑glucuronidase overexpressed in different types of human cancer, and a predicted target of microRNA (miRNA/miR)‑219a‑2‑3p in thyroid cancer. The present study aimed to investigate the potential role of HPSE and miR‑219a‑2‑3p in thyroid cancer, and the molecular mechanism of miR‑219a‑2‑3p regulating the proliferation of thyroid cancer cells via HPSE was confirmed. Immunohistochemistry analysis was performed to detect HPSE expression in thyroid cancer sections. In addition, reverse transcription‑quantitative PCR analysis was performed to detect mRNA and miR‑219a‑2‑3p expression levels in thyroid cancer samples and cell lines. miR‑219‑2‑3p mimic or HPSE plasmid were transfected into B‑CPAP and TPC‑1 thyroid cancer cells. Furthermore, western blot analysis was performed to detect the protein expression levels of HPSE and cyclin D1. Cell cycle analysis was performed using propidium iodide staining and flow cytometry, and EdU incorporation was performed to detect cell proliferation. The results demonstrated that high HPSE expression was significantly associated with tumor size, extracapsular invasion and lymph node metastasis. Notably, a statistically negative correlation was observed between HPSE mRNA expression and miR‑219a‑2‑3p expression in thyroid cancer tumors, as well as in thyroid cancer cell lines. When exogenously expressed in B‑CPAP and TPC‑1 cells, miR‑219a‑2‑3p induced cell cycle arrest at the G0/G1 phase and decreased the percentage of proliferating cells. Furthermore, HPSE and cyclin D1 protein expression decreased following transfection with miR‑219a‑2‑3p. Notably, when HPSE was ectopically expressed in miR‑219a‑2‑3p transfected cells, cyclin D1 expression and the number of proliferative cells increased. Taken together, these results suggest that HPSE contributes to the proliferation of thyroid cancer cells. In addition, miR‑219a‑2‑3p was confirmed to target HPSE and inhibit cell proliferation, which was associated with cyclin D1 suppression‑mediated cell cycle arrest.

View Figures

View References

1	Masola V, Zaza G, Gambaro G, Franchi M and Onisto M: Role of heparanase in tumor progression: Molecular aspects and therapeutic options. Semin Cancer Biol. 62:86–98. 2020.PubMed/NCBI View Article : Google Scholar
2	Zheng HY, Ruan J, Zhao P, Chen SP, Pan LL and Liu JQ: Heparanase is involved in proliferation and invasion of ovarian cancer cells. Cancer Biomark. 15:525–534. 2015.PubMed/NCBI View Article : Google Scholar
3	Chen XP, Luo JS, Tian Y, Nie CL, Cui W and Zhang WD: Downregulation of heparanase expression results in suppression of invasion, migration, and adhesion abilities of hepatocellular carcinoma cells. Biomed Res Int. 2015(241983)2015.PubMed/NCBI View Article : Google Scholar
4	Lv B, Zhang B, Hu XY and Zeng QD: Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma. Oncol Lett. 11:1327–1334. 2016.PubMed/NCBI View Article : Google Scholar
5	Lv QY, Wu KJ, Liu FL, Wu WR, Chen YR and Zhang W: Interleukin-17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer. Int J Oncol. 53:1809–1817. 2018.PubMed/NCBI View Article : Google Scholar
6	Matos LL, Suarez ER, Theodoro TR, Trufelli DC, Melo CM, Garcia LF, Oliveira OC, Matos MG, Kanda JL, Nader HB, et al: The profile of heparanase expression distinguishes differentiated thyroid carcinoma from benign neoplasms. PLoS One. 10(e0141139)2015.PubMed/NCBI View Article : Google Scholar
7	Chen XP, Jiang W, Yue CF, Zhang WJ, Tong CG, Dai DF, Cheng B, Huang C and Lu L: Heparanase contributes to trans-endothelial migration of hepatocellular carcinoma cells. J Cancer. 8:3309–3317. 2017.PubMed/NCBI View Article : Google Scholar
8	Zheng LD, Jiao WJ, Song HJ, Qu HX, Li D, Mei H, Chen YJ, Yang F, Li HH, Huang K and Tong QG: miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression. Cell Death Dis. 7(e2382)2016.PubMed/NCBI View Article : Google Scholar
9	Ma K, Xu HY, Zhang J, Zhao F, Liang HQ, Sun HT, Li P, Zhang S, Wang RJ and Chen XY: Insulin-like growth factor-1 enhances neuroprotective effects of neural stem cell exosomes after spinal cord injury via an miR-219a-2-3p/YY1 mechanism. Aging (Albany NY). 11:12278–12294. 2019.PubMed/NCBI View Article : Google Scholar
10	Wang YB, Zhao JN, Zhang CC, Wang PC, Huang CX and Peng H: MiR-219a-2-3p suppresses cell proliferation and promotes apoptosis by targeting MDM2/p53 in pituitary adenomas cells. Biosci Biotechnol Biochem. 84:911–918. 2020.PubMed/NCBI View Article : Google Scholar
11	Yang Z, Dong XH, Pu ML, Yang HW, Chang WL, Ji FH, Liu T, Wei CQ, Zhang XF and Qiu XG: LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer. Gastric Cancer. 23:449–463. 2020.PubMed/NCBI View Article : Google Scholar
12	Lloyd RV, Osamura RY, Klöppel G and Rosai J (eds): WHO Classification of Tumours of Endocrine Organs. 4th edition. IARC, Lyon, 2017.
13	Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, et al: AJCC Cancer Staging Manual. 8th edition. Springer, New York, NY, 2017.
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
15	Wang C, Wei YJ, Wang G, Zhou YM, Zhang JC and Xu K: Heparanase potentiates the invasion and migration of pancreatic cancer cells via epithelial-to-mesenchymal transition through the Wnt/β-catenin pathway. Oncol Rep. 44:711–721. 2020.PubMed/NCBI View Article : Google Scholar
16	Chen XP, Cheng B, Dai DF, Wu YH, Feng ZW, Tong CG, Wang XM and Zhao J: Heparanase induces necroptosis of microvascular endothelial cells to promote the metastasis of hepatocellular carcinoma. Cell Death Discov. 7(33)2021.PubMed/NCBI View Article : Google Scholar
17	Tang DB, Piao Y, Zhao S, Mu XD, Li S, Ma WJ, Song Y, Wang JX, Zhao WH and Zhang QY: Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer. Med Oncol. 31(26)2014.PubMed/NCBI View Article : Google Scholar
18	Zhang W, Chan H, Wei LW, Pan ZM, Zhang JQ and Li L: Overexpression of heparanase in ovarian cancer and its clinical significance. Oncol Rep. 30:2279–2287. 2013.PubMed/NCBI View Article : Google Scholar
19	Kundu S, Xiong AQ, Spyrou A, Wicher G, Marinescu VD, Edqvist PHD, Zhang L, Essand M, Dimberg A, Smits A, et al: Heparanase promotes glioma progression and is inversely correlated with patient survival. Mol Cancer Res. 14:1243–1253. 2016.PubMed/NCBI View Article : Google Scholar
20	Sheng N, Zhang L and Yang SF: MicroRNA-429 decreases the invasion ability of gastric cancer cell line BGC-823 by downregulating the expression of heparanase. Exp Ther Med. 15:1927–1933. 2018.PubMed/NCBI View Article : Google Scholar
21	Fleming J, Bell EH, Tong ZY, Grozdic I, McElroy J, Beyer S, Fabian D, Cui TT, Popp I, Staszewski O, et al: CSIG-21. The role of miR-219a-2-3p as a tumor suppressor in IDH1/2-wild-type grade II/III gliomas. Neuro Oncol. 20 (Suppl 6)(vi47)2018.